Financial Analysis: Niagen Bioscience (NASDAQ:NAGE) & Natural Alternatives International (NASDAQ:NAII)

Natural Alternatives International (NASDAQ:NAII – Get Free Report) and Niagen Bioscience (NASDAQ:NAGE – Get Free Report) are both small-cap consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings and valuation.

Volatility & Risk

Natural Alternatives International has a beta of 0.42, indicating that its share price is 58% less volatile than the S&P 500. Comparatively, Niagen Bioscience has a beta of 2.12, indicating that its share price is 112% more volatile than the S&P 500.

Insider & Institutional Ownership

32.4% of Natural Alternatives International shares are held by institutional investors. Comparatively, 15.4% of Niagen Bioscience shares are held by institutional investors. 20.5% of Natural Alternatives International shares are held by insiders. Comparatively, 10.0% of Niagen Bioscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Natural Alternatives International and Niagen Bioscience”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Natural Alternatives International $142.51 million 0.04 -$20.69 million ($3.78) -0.24
Niagen Bioscience $129.42 million 1.25 $17.38 million $0.12 17.00

Niagen Bioscience has lower revenue, but higher earnings than Natural Alternatives International. Natural Alternatives International is trading at a lower price-to-earnings ratio than Niagen Bioscience, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Natural Alternatives International and Niagen Bioscience’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Natural Alternatives International -17.22% -21.95% -9.09%
Niagen Bioscience 8.37% 10.18% 7.57%

Analyst Ratings

This is a summary of recent recommendations and price targets for Natural Alternatives International and Niagen Bioscience, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natural Alternatives International 1 0 0 0 1.00
Niagen Bioscience 0 1 4 1 3.00

Niagen Bioscience has a consensus price target of $8.50, suggesting a potential upside of 316.67%. Given Niagen Bioscience’s stronger consensus rating and higher possible upside, analysts plainly believe Niagen Bioscience is more favorable than Natural Alternatives International.

Summary

Niagen Bioscience beats Natural Alternatives International on 12 of the 15 factors compared between the two stocks.

About Natural Alternatives International

(Get Free Report)

Natural Alternatives International, Inc. (NAI) develops and manufactures nutritional supplements for customers in the dietary supplement, sports nutrition and health and wellness industries. Its contract manufacturing services include product formulation, ingredient sourcing, manufacturing, packaging and quality testing. The company also markets CarnoSyn, its branded beta-alanine ingredient used in sports nutrition products. Founded in 1980 and based in Carlsbad, California, NAI serves customers in the United States and international markets.

About Niagen Bioscience

(Get Free Report)

Niagen Bioscience, Inc. develops and markets products based on nicotinamide riboside (NR), a form of vitamin B3 studied for its role in supporting the body’s production of NAD+. Its offerings include Tru Niagen, a consumer dietary supplement, and Niagen, a branded NR ingredient supplied to other businesses. The company also conducts and supports research on NR, NAD+ and healthy aging. It was formerly known as ChromaDex Corporation and adopted the Niagen Bioscience name in 2025. Niagen Bioscience serves consumers and commercial customers in the United States and international markets through online sales, retail and distribution channels.

Receive News & Ratings for Natural Alternatives International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natural Alternatives International and related companies with MarketBeat.com's FREE daily email newsletter.